« Back
Home /
Birinapant (TL32711) 50mg

Birinapant (TL32711) 50mg

Item no.	A12738-50
Manufacturer	Adooq
CASRN	1260251-31-7
Amount	50 mg
Quantity options	10 mg 100 mg 10mM x 1mL in DMSO 2 mg 25 mg 5 mg 50 mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	CC[C&commat;&commat;H](C(=O)N1C[C&commat;H](C[C&commat;H]1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)C[C&commat;&commat;H]6C[C&commat;&commat;H](CN6C(=O)[C&commat;H](CC)NC(=O)[C&commat;H](C)NC)O)O)NC(=O)[C&commat;H](C)NC
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	TL-32711, TL 32711
Similar products	Birinapant (TL32711)
Available
Storage Conditions	2 years at -20C
Molecular Weight	806, 94
Chemical Name	(2S, 2'S)-N, N'-((2S, 2'S)-((3S, 3'S, 5R, 5'R)-5, 5'-((6, 6'-difluoro-1H, 1'H-[2, 2'-biindole]-3, 3'-diyl)bis(methylene))bis(3-hydroxypyrrolidine-5, 1-diyl))bis(1-oxobutane-2, 1-diyl))bis(2-(methylamino)propanamide)
Description	Birinapant, also known as TL32711, is a synthetic small molecule and peptido mimetic of second mitochondrial-derived activator of caspases (SMAC) and inhibitor of IAP (Inhibitor of Apoptosis Protein) family proteins, with potential antineoplastic activity.
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer